Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial
Siobhan Quenby, Katie Booth, Louise Hiller, Arri Coomarasamy, Paulien G. de Jong, Eva N. Hamulyák, Luuk J.J. Scheres, Thijs F. van Haaps, Lauren Ewington, Shreeya Tewary, Mariëtte Goddijn, Saskia Middeldorp
Topics & Concepts
MedicinePregnancyMiscarriageThrombophiliaObstetricsRecurrent miscarriagePopulationGestationRandomized controlled trialLow molecular weight heparinPediatricsAdverse effectGynecologyHeparinSurgeryInternal medicineThrombosisGeneticsEnvironmental healthBiologyBlood Coagulation and Thrombosis MechanismsHeparin-Induced Thrombocytopenia and ThrombosisCardiovascular Issues in Pregnancy